Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Cancer treatment reports

• Publication date

  1978-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 81719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

  1977cited by this paper
• Improved chemotherapy in disseminated testicular cancer.

  1977cited by this paper
• The clinical toxicity of anticancer drugs and its prediction.

  1977cited by this paper
• Combination chemotherapy in germinal cell tumors.

  1976cited by this paper
• Effects of patient selection on results of phase II chemotherapy trials in gastrointestinal cancer.

  1974cited by this paper
• Keynote address on biostatistics and data retrieval.

  1973cited by this paper
• Estimation of the probability of an event as a function of several independent variables.

  1967cited by this paper

• Cisplatin

  2023cites this paper
• Commentary 4

  2012cites this paper
• Patients with advanced non-seminomatous germ-cell tumour: the art of the start.

  2010cites this paper
• Transient vinblastine-induced thrombocytopenia during chemotherapy with vinblastine, cis-platinum and bleomycin.

  2009cites this paper
• Commentary: Combination chemotherapy of nonseminomatous testicular cancer

  2004cites this paper
• Phase I Trial Design and Methodology for Anticancer Drugs

  2004cites this paper
• Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response

  2002cites this paper
• Malnutrition and the role of nutritional support for radiation therapy patients.

  1988cites this paper
• The absence of influence of acetylsalicylic acid (ASA) on the transient decrease in platelet counts observed after infusion of bleomycin and vinblastine.

  1985cites this paper
• Chemotherapy in seminoma: when is it appropriate initial treatment?

  1985cites this paper
• Vinblastine, bleomycin, and cis-platin as salvage therapy for MOPP treated patients with Hodgkin's lymphoma.

  1984cites this paper
• The extent of surgery after chemotherapy for advanced germ cell tumors.

  1984cites this paper
• Salvage therapy of aggressive non‐Hodgkin's lymphoma with a combination of vinblastine, bleomycin, and cisplatin

  1984cites this paper
• Surgery in the management of stage III germinal cell tumors. Observations on the M.D. Anderson Hospital experience, 1971-1979.

  1984cites this paper
• Bleomycin-induced early-onset transient decrease in platelet counts.

  1984cites this paper
• Vincristine, cisplatin, and bleomycin with surgery in the management of advanced metastatic nonseminomatous testis tumors

  1984cites this paper
• Pharmacology, Clinical Efficacy and Adverse Effects of Vindesine Sulfate, A New Vinca Alkaloid

  1983cites this paper
• Early-onset thrombocytopenia in the chemotherapy of testicular teratoma.

  1983cites this paper
• Urologic Cancer: Chemotherapeutic Principles and Management

  1983cites this paper
• Chemotherapy of Testicular Cancer: From Palliation to Cure

  1983cites this paper
• Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.

  1982cites this paper
• [Unusual course in 2 patients with testicular teratoma during vinblastine-cyclophosphamide chemotherapy].

  1981cites this paper
• [Modern chemotherapy of a malignant testicular tumors (author's transl)].

  1981cites this paper
• Cisplatin: impact of a new anticancer agent on current therapeutic strategies.

  1981cites this paper
• Testicular cancer.

  1981cites this paper
• Adjuvant chemotherapy is of value following retroperitoneal lymph node dissection for nonseminomatous testicular tumors.

  1980cites this paper
• Adjuvant therapy of testis cancer: the role of vinblastine and bleomycin.

  1980cites this paper
• Chemotherapy of disseminated testicular cancer a random prospective study

  1980cites this paper
• Alterations of nutritional status. Impact of chemotherapy and radiation therapy

  1979cites this paper
• Cis-platinum: a new anticancer agent.

  1979cites this paper
• Tolerance of hemopoiesis for repeated cytotoxic drug therapy

  1979cites this paper